Navigation Links
Alpharma in Medical News

King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion

Combination to Create a Leading Specialty Pharmaceutical Company with Greater Commercialization Capabilities, Expanded Portfolio of Pain Management Products and a Strengthened Pipeline King Extends Tender Offer Through December 19, 2008 BRISTOL, Tenn. and BRIDGEWATER, N.J., Nov....

Alpharma's Reach Teach Learn Initiative Targets Youth and Consumer Awareness

...ure that honest, educated decisions are made. alpharma Inc., Animal Health announced the launch of Reach...ellinger, Global Leader, Sales & Marketing for alpharma Inc., Animal Health. "These initiatives are small ...an important role in the future of agriculture and alpharma is reaching out to help them glean a thorough unde...

Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit

...amp; Critical Care Medicine, Division of Pain Medicine, formerly Chief Medical Officer, Senior Vice President Clinical Research & Medical Affairs, alpharma Inc. For more information about this conference, please visit www.arrowheadpublishers.com , or call 1-312-244-3703, ext. 4. ### Read the f...

DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy

...rch and medical affairs for pain products while at alpharma and Abbott, and first-hand experience with the reg...(TM) and other programs." Dr. Stauffer was at alpharma Inc. from 2004 to 2009, where his latest position prior to the acquisition of alpharma by King Pharmaceuticals was as Chief Medical Offic...

Irvine Pharmaceutical Services Enhances Staff, Prepares for Innovative Expansion

...nderstanding and knowledge of the company as well as pharmaceutical development. His previous positions at highly reputable organizations such as PPD, alpharma (Actavis), Solvay Pharmaceuticals and Solvay Animal Health, to name a few, has helped develop his expertise in a range of areas, including chromatogra...

National Family Partnership Designates October 27th 'Lock Your Meds' Day

...ve social activities for youth. About Alpharma alpharma Inc. (NYSE: ALO ) is a global specialty pharmaceu...ship positions in products for humans and animals. alpharma is presently active in more than 80 countries. alpharma has a growing branded pharmaceutical franchise in ...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...als (Nasdaq: VRTX ) Add Adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) alpharma Inc. (NYSE: ALO ) Altus Pharmaceuticals Inc. (Nasdaq: ALTU ) AMAG Pharmaceuticals Inc. (Nasdaq: AMAG ) ANGIOTECH PHARMACEUTICALS (Nasdaq: AN...

Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector

...tt served as CEO of Diad Research, a technology start-up. From 1990 to 1997, he held various senior management positions with pharmaceutical companies alpharma Inc. and NMC Laboratories. Barrett is a past chairman of the Generic Pharmaceutical Association and is on the board of ambassadors of Johns Hopkins Sc...

KADIAN Efficacy Not Affected by Alcohol Consumption

...e extended-release) Capsules have been released by alpharma Inc. (NYSE: ALO), a leading pharmaceutical company... Results of this pharmacokinetic study, which alpharma conducted in response to a request by the U.S. Foo...ce President, Clinical Research & Medical Affairs, alpharma Pharmaceuticals Division Inc. "We believe this inf...
Alpharma in Medical Technology

Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting

...IDGEWATER, N.J., Sept. 9 /PRNewswire-FirstCall/ -- alpharma Inc. (NYSE: ALO ), a global specialty pharmaceuti...ogic abuse-deterrent, extended-release opioid that alpharma is developing for the treatment of moderate to sev... President of Clinical Research & Medical Affairs, alpharma Pharmaceuticals. "We look forward to collaborating...

Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session

... TAMPA, Fla., May 8 /PRNewswire-FirstCall/ -- alpharma Inc. (NYSE: ALO ), a global specialty pharmaceuti...ogic abuse-deterrent, extended-release opioid that alpharma is developing for the treatment of moderate to sev...eating patients with chronic pain." On April 21, alpharma announced that it withdrew its New Drug Applicatio...

Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions

...AID TAMPA, Fla., May 8 /PRNewswire-FirstCall/ -- alpharma Inc. (NYSE: ALO ), a leading global specialty pha...lerability and positive pharmacokinetic profile of alpharma Pharmaceuticals' FLECTOR(R) Patch (diclofenac epol... President, Clinical Research and Medical Affairs, alpharma Pharmaceuticals. "In addition to supporting the ef...

Alpharma Presents Positive Pharmacokinetic Study Results of Its Investigational Abuse-Deterrent, Extended-Release Opioid

...h & Medical Affairs and Senior Vice President, alpharma Pharmaceuticals LLC. "We are committed to offering...="http://www.kadian.com/">www.KADIAN.com . About alpharma alpharma Inc. is a global specialty pharmaceutical company ...
Alpharma in Biological Technology

DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective

CUPERTINO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX ) announced today that the previously announced development and license agreement with Alpharma Ireland Limited, an affiliate of Alpharma Inc. (NYSE: ALO ), granting such party the exclusive worldwide right...

DURECT Corporation Announces Third Quarter 2008 Financial Results

... receipt of a $20 million upfront license fee from alpharma in the fourth quarter of 2008 and a review of proj...r us was the establishment of a collaboration with alpharma to develop and commercialize our ELADUR(TM) bupiva...ered into a development and license agreement with alpharma Ireland Ltd., an affiliate of Alpharma, Inc., gran...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

... ALKERMES INC. (NASDAQ: ALKS ) ALLERGAN INC. (NYSE: AGN ) ALLOS THERAPEUTICS INC. (NASDAQ: ALTH ) ALNYLAM PHARMACEUTICALS INC. (NASDAQ: ALNY ) alpharma INC. (NYSE: ALO ) ALTUS PHARMACEUTICALS INC. (NASDAQ: ALTU ) AMAG PHARMACEUTICALS INC. (NASDAQ: AMAG ) ANGIOTECH PHARMACEUTICALS INC. (TSE: ANP)...

Informed Medical Communications Appoints New Chief Financial Officer

...shares doubled and the company saw a dramatic improvement in cash flow. Prior to this, Marchio helped finance the domestic and international growth of alpharma from under $300MM in sales (1992) to approximately $1.3B (2005) while building treasury, tax, risk management and benefit finance systems as their Vic...

Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales

...o market, specifically with testing products and in the diabetes arena." Prior to joining Synvista, Mr. Tantillo was Director Strategic Marketing at alpharma Pharmaceuticals. From 2006 to 2007, he was U.S. Marketing Director at Mayne Pharma, which was acquired by Hospira. Prior to that, from 2004 to 2005 he...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...uticals (Nasdaq: VRTX ) Add Adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) alpharma Inc. (NYSE: ALO ) Altus Pharmaceuticals Inc. (Nasdaq: ALTU ) AMAG Pharmaceuticals Inc. (Nasdaq: AMAG ) ANGIOTECH PHARMACEUTICALS (Nasdaq: ANPI ...
Other Tags
(Date:8/28/2015)... , ... August 28, 2015 , ... For Dallas, the ... taking part with their subsidiary USPI Tenet Health. , The American Heart Association hosts ... disease and stroke. They believe that together, a difference can be made. Walkers can ...
(Date:8/28/2015)... ... August 28, 2015 , ... The 6th Annual Survivor ... Aneurysm Foundation has added yet another accolade to its cadre of widespread support—an official ... , “With the help of the medical community and the University of Illinois at ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL —Pocket ... zero fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. ... SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... nationwide. Addictions specialist, Dr. James Strawbridge, gives a new approach on solutions in ... should begin with the employer and employees getting together for meaningful group meetings. ...
(Date:8/28/2015)... Jordan, Utah (PRWEB) , ... August 28, 2015 ... ... been awarded a three-year accreditation for its adolescent residential, counseling, day treatment and ... demonstrates that it meets international standards for quality and its pursuit of excellence. ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2
(Date:8/25/2015)... and BELLEVUE, Wash. , ... in advanced robotic systems, announced today it will unveil ... ground vehicle (UGV), at the National Tactical Officers Association ... The Guardian S is the first-ever commercially ... of years of research and in-field trials and is ...
(Date:8/20/2015)... 2015   Sensory, Inc ., a Silicon ... experience and security of consumer electronics through state-of-the-art ... its TrulySecure™ is the first multimodal ... FIDO Certified™. The FIDO (Fast Identification ... FIDO UAF (Universal Authentication Framework) 1.0 specifications, which ...
(Date:8/18/2015)... , Aug. 17, 2015 Research and ... of the "Global Biometric Authentication & Identification ... Estimation & Forecast, 2015-2020" report to their ... and identification systems market is expected to grow ... to 2020 and generate over $25 billion (approximately) ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2
Other Contents